Linahenz M OD 1000mg/5mg Tablet ER
Linahenz M OD 1000mg/5mg Tablet ER
Metformin (1000mg) + Linagliptin (5mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Linahenz M OD 1000mg/5mg Tablet ER is a combination oral antidiabetic medication containing Metformin hydrochloride 1000mg and Linagliptin 5mg, formulated for extended-release administration. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production, enhancing peripheral glucose uptake, and improving insulin sensitivity, thereby aiding in glycemic control. Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, increases incretin hormone levels, which in turn stimulate insulin secretion and suppress glucagon release in a glucose-dependent manner. This combination is indicated for the management of type 2 diabetes mellitus in adults when diet and exercise alone do not provide adequate glycemic control. The extended-release formulation allows for once-daily dosing, improving patient adherence and minimizing gastrointestinal side effects commonly associated with immediate-release Metformin. Linahenz M OD should be used with caution in patients with renal impairment, hepatic dysfunction, or conditions predisposing to lactic acidosis. Regular monitoring of blood glucose levels, renal function, and potential adverse effects is recommended during therapy. This medication is not indicated for type 1 diabetes or diabetic ketoacidosis. Linahenz M OD 1000mg/5mg Tablet ER offers a synergistic approach to glycemic management by targeting multiple pathophysiological defects in type 2 diabetes.
Active composition
Linagliptin 5 mg
+1 more active ingredient
About Linagliptin
Linagliptin is an oral medication used to manage type 2 diabetes mellitus. It belongs to the class of DPP-4 inhibitors, which work by increasing insulin secretion and decreasing glucagon levels in response to meals. This helps lower blood glucose levels effectively. Linagliptin is often prescribed alongside diet and exercise to improve glycemic control. Side effects may include upper respiratory infections and headache. In summary, Linagliptin is a valuable option for managing type 2 diabetes.
How It Works
Linagliptin inhibits the enzyme DPP-4, leading to increased levels of incretin hormones, which promote insulin secretion and inhibit glucagon release, thereby lowering blood glucose levels.
All Active Ingredients
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Linahenz M OD 1000mg/5mg Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Pregnancy
Linahenz M OD 1000mg/5mg Tablet ER is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Driving
There is limited information available on the use of Linahenz M OD 1000mg/5mg Tablet ER in patients with kidney disease. Please consult your doctor.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
There is limited information available on the use of Linahenz M OD 1000mg/5mg Tablet ER in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Linahenz M OD 1000mg/5mg Tablet ER
